CTHRC1 and breast carcinoma: In addition, Rodr et al. [18] and Bockhorn et al. [19] have successively reported the low expression of miR-30c was associated to poor prognosis in breast cancer, whereas our data showed CTHRC1 high-expression indicated poor prognosis.